DICAM, a molecular passport for T H 17 cell entry into the brain.
Sachin P GadaniMichael D KornbergPublished in: Science translational medicine (2022)
DICAM, a trafficking molecule preferentially expressed by T H 17 cells, may be a therapeutic target for treating neuroinflammation (Charabati et al. ).
Keyphrases
- induced apoptosis
- cell cycle arrest
- cerebral ischemia
- single cell
- cell therapy
- white matter
- resting state
- endoplasmic reticulum stress
- lipopolysaccharide induced
- cognitive impairment
- lps induced
- cell death
- stem cells
- signaling pathway
- oxidative stress
- brain injury
- mesenchymal stem cells
- subarachnoid hemorrhage
- bone marrow